Pharmacokinetic dosing of aminoglycosides: a controlled trial. - Wikidata - wikimedia - TriplyDB

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

http://www.wikidata.org/entity/Q44361848

about

Computerized advice on drug dosage to improve prescribing practice Acute kidney injury in the perioperative period and in intensive care units (excluding renal replacement therapies)Dose optimisation of antibiotics in children: application of pharmacokinetics/pharmacodynamics in paediatrics Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective Inhibition of aminoglycoside-deactivating enzymes APH(3')-IIIa and AAC(6')-Ii by amphiphilic paromomycin O2''-ether analogues Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series.Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock Outcomes in patients with gram-negative sepsis treated with gentamicin How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?Management of infectious complications in the hematopoietic stem cell transplant recipient.Providing guidelines and education is not enough: an audit of gentamicin use at The Royal Melbourne Hospital.Usage Pattern and Serum Level Measurement of Amikacin in the Internal Medicine Ward of the Largest Referral Hospital in the South of Iran: A Pharmacoepidemiological Study.Plasma Peak and Trough Gentamicin Concentrations in Hospitalized Horses Receiving Intravenously Administered Gentamicin.Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases.Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America Pharmacological rationale for antibiotic treatment of intra-abdominal infections.Bile-mediated aminoglycoside sensitivity in Lactobacillus species likely results from increased membrane permeability attributable to cholic acid The strategy of antibiotic use in critically ill neutropenic patients Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA).Aminoglycosides in septic shock: an overview, with specific consideration given to their nephrotoxic risk.Approaches for dosage individualisation in critically ill patients.Aminoglycoside-induced nephrotoxicity--a focus on monitoring: a review of literature.Therapeutic drug monitoring of anti-infective agents in critically ill patients.Estimating drug-free period using a graphical method: an alternative way to monitor extended-interval dosing of gentamicin therapy.Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis Augmenting effect of antibiotics on endotoxin activity may cause a safety problem.Stability and antimicrobial effect of amikacin-loaded solid lipid nanoparticles.Adsorption of amikacin, a significant mechanism of elimination by hemofiltration Once versus individualized multiple daily dosing of aminoglycosides in critically ill patients Gentamicin-associated acute kidney injury.Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.Comparative pharmacokinetics of amikacin in Greyhound and Beagle dogs.Pharmacokinetics and pharmacogenetics of anti-tubercular drugs: a tool for treatment optimization?Therapeutic drug monitoring of once daily aminoglycoside dosing: comparison of two methods and investigation of the optimal blood sampling strategy.Factors affecting gentamicin penetration in lower extremity ischemic tissues with ulcers.Acute kidney injury in non-critically ill children treated with aminoglycoside antibiotics in a tertiary healthcare centre: a retrospective cohort study.

P2860

Q24202497-BB2D4AE2-9FCC-437A-B97F-B6BBF8348EF8 Q26745670-5188E973-EA61-40EE-A190-844DDA9EB99E Q26853629-0E320A17-C5FC-455E-9519-51E909ABA8DA Q27009221-590AA092-4663-4AE2-B783-FAEC1014A6BF Q27673672-2A7D60EE-FD99-4ABE-AAEA-04D1C311A1D1 Q28068503-07F740CF-65B1-4EC3-9575-A6C1EC59CB48 Q30830192-FBB6E620-C847-4AA7-AEC3-658BE86BDB26 Q33919190-C70039DB-98AB-4463-9B18-6970B222F16B Q33949330-8D357176-E3E8-4ADF-8AA5-623852A2B737 Q34894900-D9CE3030-DB8E-411C-B689-7C44598A69D9 Q35675979-7D1D6371-AB3A-4D58-969B-A2379FF59269 Q36366980-16F65FE0-C40F-4D80-8799-E88BBC3373F8 Q36925002-5C801E02-5B6D-4D83-BBE9-77D11296FDF4 Q36975688-E153D83D-76C2-43E7-857D-139007E3A4D5 Q37050322-EE6CADED-54FA-4BD6-B224-D5047C3A28BC Q37220711-874605D1-F99B-486F-9695-82FDBB58485C Q37557851-556163C8-DC36-4766-A920-FD07FEE4FC06 Q37701873-13DAE87A-48D7-4BB3-ACD9-CD0900A34D26 Q37929895-5F67D3D2-E216-42F1-A26A-4444A959A8CB Q38070006-591495C6-9A60-4143-9DC9-F010FCD8A6B1 Q38090988-0814A85A-5C5C-4F8B-9BBD-56FDCC7040EA Q38125209-6E6A2046-430E-4205-BF6D-498070997F6F Q38239999-C3A98713-5595-41BB-A677-F87F21A1B7CF Q38790740-FAE21B6B-9634-4C2A-9270-A4B4D77EB288 Q39015529-9BD96FA1-302C-4297-8880-7AFA03E5CCCC Q39030684-7DE3FAF2-A178-44A9-80EA-B0421E87C048 Q40586961-4E516BDA-ACCA-44A4-A60F-7E611B98D522 Q41948736-12D20846-401E-4B6A-90B6-C1759465925F Q42133019-B9F4F6C6-E806-4550-A116-9D349111BC86 Q42556968-C30D55F7-F5B7-4FBA-94D9-081CD3BE3052 Q43263735-F05C3C41-96BB-4CB6-B88C-576EB68F298D Q45978260-A6232E56-55EA-41A9-BDA6-27CA6597A3C4 Q46728031-730C180A-245D-483B-9263-863DFC5BC882 Q47332682-58B424C4-1690-4F99-9938-63AAEE2D7122 Q51092520-7FCBF8C2-40E4-491D-9F31-EE347A71106A Q51423932-2579B75C-8F97-4832-88DF-549680B03EA2 Q51813710-68E667D3-0AF5-4E17-B153-3A99BB38A4FC

P2860

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

http://www.wikidata.org/entity/Q44361848

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@en

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@nl

type

label

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@en

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@nl

prefLabel

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@en

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@nl

P1433

Q44361848-53022E66-C95C-497A-AC43-65DB151F2C07

P1476

Q44361848-044A8C4C-64C5-4343-B09E-3D7F6AAEC92F

P2093

Q44361848-1C45B2BD-8ADE-4529-BCE4-8B1600150D7B

Q44361848-44D88F2D-6C76-4DC3-9067-80CB074710EB

Q44361848-4B6A7843-1BC5-4020-BBE1-CB27669A2350

Q44361848-6355EA56-D0E3-4C99-9E16-DB212F006B27

Q44361848-B45B8254-D9A5-42D8-9AA6-B47F690010C2

Q44361848-EB453AB5-B3A5-4788-9DCC-7AF0A83F8D8C

Q44361848-EF90522F-0E1F-412F-ACF6-77A35BBF17C3

Q44361848-FC7F2D4C-A2B2-4841-A23D-B4733C12A87C

P304

Q44361848-C859F267-C6DE-4DA5-9704-7DDF0C87DA6F

P31

Q44361848-5E6303EA-B369-4DEC-9A57-B78F34DB1F19

P356

Q44361848-679F6DDD-E99F-45CE-A2DE-438665BE3B53

P407

Q44361848-94A6E687-F491-4C73-9283-9B4D100EE5CC

P433

Q44361848-187B2CE7-7CA7-4E7A-8A7C-111F90A5CA36

P478

Q44361848-9691B3C6-C8A7-47D7-848C-933C4263834A

P577

Q44361848-1D5872F6-99D9-4A4F-9F4F-44C375AE6243

P698

Q44361848-67EA063D-05F6-4F67-86BE-0B85B3201316

P356

S0002-9343(02)01476-6

P1433

The American Journal of Medicine

P1476

Pharmacokinetic dosing of aminoglycosides: a controlled trial.

@en

P2093

Abraham Danon

http://www.w3.org/2001/XMLSchema#string

Aviel Sidi

http://www.w3.org/2001/XMLSchema#string

Carmi Bartal

http://www.w3.org/2001/XMLSchema#string

Francisc Schlaeffer

http://www.w3.org/2001/XMLSchema#string

Klaris Reisenberg

http://www.w3.org/2001/XMLSchema#string

Michael Alkan

http://www.w3.org/2001/XMLSchema#string

Rosa Smoliakov

http://www.w3.org/2001/XMLSchema#string

Yaniv Almog

http://www.w3.org/2001/XMLSchema#string

P304

194-198

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0002-9343(02)01476-6

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

114

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12637133

http://www.w3.org/2001/XMLSchema#string